Company intelligence / Profile preview
Laboratorios Liomont
- Ownership
- Private
- Employees
- ~1400
- Development stage
- Commercial
Overview
Liomont has a long history of commercialized prescription and OTC products in Mexico and Latin America. The company’s pipeline includes preclinical-stage biologics for asthma and pending-stage combination drugs for pain management. It played a key role in the fill-finish process for AstraZeneca’s COVID‑19 vaccine during the pandemic. No recent clinical trial results are publicly detailed.
- Therapeutic areas
- PulmonologyNeurologyInfectious Diseases
- Modalities
- Monoclonal antibodies (mAbs)small molecules (analgesics, antibiotics, antispasmodics, antihypertensives, anti-inflammatories)combination drugs
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Laboratorios Liomont.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Laboratorios Liomont.